State Street Corp Relmada Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 99,235 shares of RLMD stock, worth $326,483. This represents 0.0% of its overall portfolio holdings.

Number of Shares

99,235

Previous 105,879 6.28%

Holding current value

$326,483

Previous $317,000 1.26%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.3 - $4.36 $15,281 - $28,967	-6,644 Reduced 6.28%	99,235 $321,000
Q2 2024 Aug 14, 2024	SELL	$2.93 - $4.94 $15,382 - $25,935	-5,250 Reduced 4.72%	105,879 $317,000
Q1 2024 May 15, 2024	SELL	$3.1 - $6.8 $12,710 - $27,880	-4,100 Reduced 3.56%	111,129 $516,000
Q3 2023 Nov 14, 2023	SELL	$2.48 - $3.79 $35,216 - $53,818	-14,200 Reduced 10.97%	115,229 $345,000
Q2 2023 Aug 14, 2023	SELL	$2.22 - $3.54 $936,100 - $1.49 Million	-421,667 Reduced 76.51%	129,429 $318,000
Q1 2023 May 15, 2023	BUY	$2.24 - $4.76 $124,013 - $263,527	55,363 Added 11.17%	551,096 $1.25 Million
Q4 2022 Feb 14, 2023	SELL	$2.17 - $35.84 $204,850 - $3.38 Million	-94,401 Reduced 16.0%	495,733 $1.73 Million
Q3 2022 Nov 15, 2022	SELL	$18.3 - $37.02 $202,233 - $409,108	-11,051 Reduced 1.84%	590,134 $21.8 Million
Q2 2022 Aug 15, 2022	BUY	$16.5 - $30.34 $2.57 Million - $4.72 Million	155,621 Added 34.93%	601,185 $11.4 Million
Q1 2022 May 16, 2022	BUY	$16.72 - $26.99 $2.04 Million - $3.3 Million	122,163 Added 37.77%	445,564 $12 Million
Q4 2021 Feb 14, 2022	SELL	$16.93 - $26.82 $41,817 - $66,245	-2,470 Reduced 0.76%	323,401 $7.29 Million
Q3 2021 Nov 15, 2021	BUY	$21.86 - $34.77 $343,355 - $546,132	15,707 Added 5.06%	325,871 $8.54 Million
Q2 2021 Aug 16, 2021	BUY	$29.55 - $39.15 $578,559 - $766,517	19,579 Added 6.74%	310,164 $9.93 Million
Q1 2021 May 17, 2021	SELL	$31.52 - $39.28 $437,308 - $544,970	-13,874 Reduced 4.56%	290,585 $10.2 Million
Q4 2020 Feb 16, 2021	BUY	$29.88 - $39.8 $63,883 - $85,092	2,138 Added 0.71%	304,459 $9.76 Million
Q3 2020 Nov 10, 2020	BUY	$34.42 - $43.78 $604,071 - $768,339	17,550 Added 6.16%	302,321 $11.4 Million
Q2 2020 Aug 14, 2020	BUY	$31.59 - $49.98 $8.73 Million - $13.8 Million	276,371 Added 3290.13%	284,771 $12.7 Million
Q1 2020 May 11, 2020	BUY	$23.78 - $50.12 $199,752 - $421,008	8,400 New	8,400 $287,000

Others Institutions Holding RLMD

# of Institutions

Shares Held

12.3M

Call Options Held

229K

Put Options Held

138K

View Full List

About RELMADA THERAPEUTICS, INC.

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $94.1M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

More about RLMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Relmada Therapeutics, Inc. Transaction History